Core Insights - Alphabet has invested $754 million in three high-growth stocks that have increased by 120% or more in 2025 [1][4] Group 1: Alphabet's Investments - Alphabet's largest equity holding is in AST Spacemobile, valued at approximately $418 million, representing 19.6% of its investment portfolio as of June 30, 2025 [3] - Alphabet holds a $195 million stake in Planet Labs, which has seen its share price rise over 120% in 2025 [6] - Another $141 million is invested in Metsera, a biotech company, which has nearly tripled in stock value year to date [8] Group 2: Company Profiles - AST Spacemobile is developing a space-based cellular broadband network accessible by smartphones, with plans for U.S. service by year-end and expansion into Canada, Japan, and the U.K. in early 2026 [4] - Planet Labs, founded by three NASA scientists, provides satellite imagery and geospatial solutions, with a market cap of $4 billion [7] - Metsera focuses on obesity treatments and is currently in phase 1 and phase 2 clinical testing [8] Group 3: Analyst Opinions - Wall Street analysts are mixed on AST Spacemobile, with only four out of ten rating it as a "buy" and an average price target 19% below the current share price [10] - For Metsera, two out of four analysts rated it as a "buy," with a consensus price target indicating less than 6% upside potential [11] - Planet Labs is favored by analysts, with five out of nine rating it as a "buy" and an average price target over 12% above the current share price [12][13] Group 4: Financial Performance - Planet Labs reported a net loss of $22.6 million in Q2 2025, with a price-to-sales ratio of 16.9, despite a year-over-year revenue growth of 20% [14] - The company's backlog increased by 245% year-over-year to $736.1 million, significantly exceeding its revenue guidance for 2025 [15]